Skip to main content
SpringerLink
Log in

Keep eye drops & nasal sprays out of reach of children, warns FDA

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. FDA.FDA Drug Safety Communication: Serious adverse events from accidental ingestion by children of over-the-counter eye drops and nasal sprays. Internet Document: 25 Oct 2012. Available from: URL: http://www.fda.gov

Download references

Additional information

Key words

Pharmacovigilance; Mydriasis; Vomiting; Infants; Children; Unconsciousness; Hypotension; Tetryzoline; Somnolence; adverse reactions; Tachycardia; Hypothermia; drug-induced; Bradycardia; Coma; Naphazoline; Adverse-reaction-monitoring; Lethargy; Nausea; Hypertension; Respiration-disorders; Oxymetazoline; Sialorrhoea

Rights and permissions

Reprints and permissions

About this article

Cite this article

Keep eye drops & nasal sprays out of reach of children, warns FDA. React. Wkly. 1426, 3 (2012). https://doi.org/10.2165/00128415-201214260-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201214260-00006

Keywords

Search

Navigation